Zentek Files Provisional Patent Application for Absorption-Based EMI Shielding Coating Made from Albany Graphite

Zentek files a patent for a graphite-based EMI coating, but commercialization is distant.

What the company is saying

Zentek Ltd. announces the filing of a provisional patent application with the United States Patent and Trademark Office for ZEN-EMI-01, an electromagnetic interference shielding coating made from graphite sourced at its Albany deposit in Ontario. The company frames this filing as the foundation for protecting its EMI shielding platform, emphasizing the novelty and technical promise of its water-based, absorption-focused coating. Internal laboratory results are highlighted, with claims of significant reduction of X-band microwave frequencies using a thin coating layer. The announcement underscores the ultra-high purity of Albany graphite, referencing independent bench-scale testing at 99.9992% purity and 2.60 ppm boron content, and positions the project as a potential critical mineral source for North American nuclear and defense supply chains. Language throughout is optimistic, with repeated references to potential applications and strategic value, but all commercial and third-party validation steps are described as future objectives. No mention is made of financial results, commercial partnerships, or binding agreements, and the tone relies on technical achievement and anticipated market relevance.

What the data suggests

The only realised milestones are the patent filing and internal laboratory test results. Laboratory data shows that a coating layer about two sheets of paper thick reduced reflected X-band (8–12 GHz) microwave signals to below 5 dB, indicating technical efficacy in a controlled environment. Albany graphite's purity is independently confirmed at 99.9992% with 2.60 ppm boron, supporting claims of suitability for high-spec applications. No commercial-scale tests, third-party performance benchmarks, or real-world application data are disclosed. There are no financial figures, revenue impacts, or cost disclosures, and no evidence of product adoption or customer engagement. The technical data is specific and credible for the laboratory stage, but there is a complete absence of metrics that would allow assessment of commercial viability, market demand, or financial trajectory. All forward-looking claims about market potential, supply chain relevance, and application breadth remain unsubstantiated by external validation or financial outcomes.

Analysis

The announcement is framed with a positive tone, highlighting the filing of a provisional patent and promising laboratory results for ZEN-EMI-01. However, most claims of commercial potential, application breadth, and supply chain impact are forward-looking and not yet realised. The only realised milestones are the patent filing and internal lab results; all commercial, third-party validation, and scale-up steps remain future goals. The execution distance is long-term, as the product is at the laboratory stage and requires further development, third-party testing, and process scale-up before any commercial impact. The mention of scale-up and process development signals future capital requirements, but there is no immediate earnings impact or financial disclosure. The gap between narrative and evidence is moderate: technical lab data is provided, but commercial and financial outcomes are entirely aspirational.

Risk flags

• ●Execution risk is high because ZEN-EMI-01 is only at the laboratory stage, with all commercial, third-party validation, and scale-up steps pending. The company itself states there is no assurance of a commercial product or granted patent, making future progress uncertain.
• ●Disclosure risk is significant due to the absence of financial data, commercial agreements, or customer engagement metrics. Without revenue, cost, or funding details, investors cannot assess the project's financial sustainability or capital requirements.
• ●Market adoption risk is present because all claims of application breadth, supply chain relevance, and strategic value are forward-looking and unsupported by external validation or binding agreements. The gap between technical promise and market reality remains unbridged.
• ●Capital intensity risk is flagged by the mention of process scale-up and manufacturing development, which typically require substantial investment. The announcement does not specify how these activities will be funded or whether sufficient resources are available.

Bottom line

This announcement marks a technical milestone for Zentek, with a provisional patent filing and positive internal lab results for a graphite-based EMI shielding coating. The data supports laboratory efficacy and high material purity, but there is no evidence of commercial traction, third-party validation, or financial impact. All market relevance and supply chain claims are aspirational, with value realisation dependent on future development, external testing, and successful scale-up. The absence of financial disclosure or partnership details limits the ability to assess risk-adjusted upside. Investors should treat this as an early-stage R&D update with no immediate investment impact; the most important takeaway is that commercialisation remains a distant prospect, and future updates must deliver third-party validation or commercial agreements to change the investment case.

Announcement summary

(TSXV:ZEN) (NASDAQ:ZTEK) Zentek Ltd. has filed a provisional patent application with the United States Patent and Trademark Office covering ZEN-EMI-01, a water-based electromagnetic interference shielding coating produced from purified graphite from the Company's Albany deposit. In internal laboratory testing, a layer of ZEN-EMI-01 approximately the thickness of two sheets of paper significantly reduced a band of microwave EM frequencies commonly used in radar and satellite communication. The frequency band tested was 8-12 GHz, known in radar engineering as the "X-band." Testing revealed the reflected portion of the signal measured below 5 decibels (dB) across the entire tested range. The Albany Graphite Project is an igneous-hosted graphite deposit located in Northern Ontario, near Hearst, Ontario, held through the Company's wholly-owned subsidiary Albany Graphite Corp. Independent bench-scale testing conducted as previously disclosed by the Company on September 22, 2025, confirmed ultra-high purity of 99.9992% with an equivalent boron content of 2.60 ppm, meeting published benchmarks for potential nuclear-grade applications. The Project is being advanced as a potential domestic North American source of critical-grade graphite for nuclear, defence and allied-nation supply chains.

Disagree with this article?